213 related articles for article (PubMed ID: 2844657)
21. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus.
Muller S; Guichard G; Benkirane N; Brown F; Van Regenmortel MH; Briand JP
Pept Res; 1995; 8(3):138-44. PubMed ID: 7670228
[TBL] [Abstract][Full Text] [Related]
22. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus.
Blanco E; Garcia-Briones M; Sanz-Parra A; Gomes P; De Oliveira E; Valero ML; Andreu D; Ley V; Sobrino F
J Virol; 2001 Apr; 75(7):3164-74. PubMed ID: 11238843
[TBL] [Abstract][Full Text] [Related]
23. Host cell selection of antigenic variants of foot-and-mouth disease virus.
Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
[TBL] [Abstract][Full Text] [Related]
24. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus.
Mateu MG; Andreu D; Domingo E
Virology; 1995 Jun; 210(1):120-7. PubMed ID: 7793064
[TBL] [Abstract][Full Text] [Related]
25. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
[TBL] [Abstract][Full Text] [Related]
26. Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications.
Yang M; Clavijo A; Li M; Hole K; Holland H; Wang H; Deng MY
J Immunol Methods; 2007 Apr; 321(1-2):174-81. PubMed ID: 17320098
[TBL] [Abstract][Full Text] [Related]
27. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
[TBL] [Abstract][Full Text] [Related]
28. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
29. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1.
Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F
Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534
[TBL] [Abstract][Full Text] [Related]
30. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus.
Francis MJ; Hastings GZ; Brown F; McDermed J; Lu YA; Tam JP
Immunology; 1991 Jul; 73(3):249-54. PubMed ID: 1652552
[TBL] [Abstract][Full Text] [Related]
31. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM
J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
[TBL] [Abstract][Full Text] [Related]
32. Serotype-independent detection of foot-and-mouth disease virus.
Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
[TBL] [Abstract][Full Text] [Related]
33. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1.
Butchaiah G; Rao BU
Acta Virol; 1989 Mar; 33(2):121-30. PubMed ID: 2569807
[TBL] [Abstract][Full Text] [Related]
34. Multiple variants in foot-and-mouse disease virus (FMDV) populations: the Achilles heel for peptide and rec. DNA vaccines?
Barteling SJ; Woortmeyer R
Dev Biol Stand; 1987; 66():511-21. PubMed ID: 3034708
[TBL] [Abstract][Full Text] [Related]
35. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
[TBL] [Abstract][Full Text] [Related]
36. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the immune response against mixotope peptide libraries from a main antigenic site of foot-and-mouth disease virus.
Oliveira Ed; Jiménez-Clavero MA; Núñez JI; Sobrino F; Andreu D
Vaccine; 2005 Apr; 23(20):2647-57. PubMed ID: 15780448
[TBL] [Abstract][Full Text] [Related]
38. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
Stave JW; Card JL; Morgan DO
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
[TBL] [Abstract][Full Text] [Related]
39. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
Vasantha S; Antony A; Lal SM
Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
[TBL] [Abstract][Full Text] [Related]
40. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV
Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
